Michael Ferguson (biochemist)

Michael Anthony John Ferguson CBE, FRS, FRSE (born c.1957) is a British biochemist and director of the Discovery Centre for Translational and Interdisciplinary Research at the University of Dundee.[1]

Career

He was awarded a B.Sc in biochemistry by the University of Manchester Institute of Science and Technology in 1979 and a Ph.D in biochemistry by London University in 1982. He was a Postdoctoral Fellow at the Rockefeller University, New York (1982–85) and at Oxford University (1985–88). He then accepted a lectureship at the University of Dundee and was promoted to Professor of Molecular Parasitology in 1994. He became Dean of Research for the School of Life Sciences at The University of Dundee in 2007, a position he held until 2014.

His main research interests concern the biochemistry of protozoan parasites that cause tropical diseases, particularly the trypanosomatida that cause human African sleeping sickness, Chagas' disease and leishmaniasis. He was heavily involved in establishing the new Drug Discovery Unit at the University of Dundee and is also co-Director of the Dundee Proteomics Facility.

He still continues to play a role in Research Strategy and directs the Discovery Centre for Translational and Interdisciplinary Research which opened in 2014. He is also a member of the Board of Governors for The Wellcome Trust and the Board of Directors of the Medicines for Malaria Venture (MMV).

Honours and awards

References

  1. ↑ "The Ferguson Lab - biography". University of Dundee. Retrieved 2 May 2018.
  2. ↑ "Michael Ferguson biography". Royal Society. Retrieved 2 May 2018.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.